UBS Group’s Direxion Daily Pharmaceutical & Medical Bear 2X Shares PILS Stock Holding History

UBS Group’s Portfolio PILS Stock Details PILS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-96,800	Closed	-$5.08M	–	8776
2015 Q3	$5.08M	Buy	+96,800	New	+$4.44M	﹤0.01%	1910

UBS Group's PILS Position: Q4 2015 in Review

UBS Group sold out of Direxion Daily Pharmaceutical & Medical Bear 2X Shares (PILS) in Q4 2015, closing a stake of 96,800 shares — an estimated $5.08M sold.

UBS Group first reported a position in PILS in Q3 2015 and held it in 1 quarter. The position peaked at $5.08M in Q3 2015. 0 funds tracked by Wall St. Rank hold PILS as of Q4 2015.

UBS Group reported no remaining Direxion Daily Pharmaceutical & Medical Bear 2X Shares position as of Q4 2015 after selling out during the quarter.
UBS Group sold 96,800 Direxion Daily Pharmaceutical & Medical Bear 2X Shares shares in Q4 2015, an estimated $5.08M.
UBS Group first reported a position in Direxion Daily Pharmaceutical & Medical Bear 2X Shares in Q3 2015 and held it in 1 quarter.
UBS Group's Direxion Daily Pharmaceutical & Medical Bear 2X Shares position peaked at $5.08M in Q3 2015.
0 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bear 2X Shares as of Q4 2015.

Based on UBS Group's 13F filing for Q4 2015, filed 16 Feb 2016.